Trial Profile
A Randomized, Comparative Trial of Concor AM, a Fixed Dose Combination of Bisoprolol and Amlodipine, on the Treatment of Essential Hypertensive Patients Whose Blood Pressure is Not Well Controlled by Monotherapy of Bisoprolol 5mg or Amlodipine 5mg
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 09 Dec 2018
Price :
$35
*
At a glance
- Drugs Amlodipine/bisoprolol (Primary)
- Indications Essential hypertension
- Focus Registrational; Therapeutic Use
- Sponsors Merck KGaA
- 18 Jun 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 10 Feb 2015 Planned End Date changed from 1 Sep 2015 to 1 May 2015 as reported by ClinicalTrials.gov record.
- 10 Feb 2015 Planned primary completion date changed from 1 Sep 2015 to 1 Mar 2015 as reported by ClinicalTrials.gov record.